Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

about

The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets.Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.

P2860

Q45325755-6E00852F-13F5-48C3-AA8E-FD5A9EFA4E15 Q50019794-4188AFDE-C5A1-48F7-930D-F718AFFCD3A0

P2860

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

Item

http://www.wikidata.org/entity/Q47717341

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

@en

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

@nl

type

Item

label

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

@en

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

@nl

prefLabel

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

@en

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

@nl

P1476

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer

@en

P2093

Aneta Cymbaluk-Płoska

http://www.w3.org/2001/XMLSchema#string

Bogusław Machaliński

http://www.w3.org/2001/XMLSchema#string

Ewa Pius-Sadowska

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor angiogenesis: therapeutic implications

Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer.

The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancer.

Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.

Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis.

ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.

Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of TGF-β1.

Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma

Androgen and fibroblast growth factor 8 (FGF8) downregulation of thrombospondin 1 (TSP1) in mouse breast cancer cells.

Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.

P304

31-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/CBM-161546

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A Chudecka-Głaz

Janusz Menkiszak

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28655131

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

about

P2860

P2860

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921